查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824210

全球感染疾病控制市场 - 预测 2025-2030

Global Infection Control Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

感染疾病预防措施的市场规模

感染疾病控制市场预计将从 2025 年的 504.11 亿美元成长到 2030 年的 620.63 亿美元，复合年增长率为 4.25%。

感染疾病控制市场涵盖旨在最大程度降低感染和病毒传播风险的实践和程序，尤其是在医院和医疗机构中。该市场致力于预防透过人际接触、受污染表面和空气传播的细菌和病毒性疾病，是保障病患安全和设施管理的关键医疗基础设施。

市场基础及临床意义

感染疾病控制措施是预防医院内获得性感染 (HAI) 的关键措施。医院内获得性感染发生在病人住院期间，是医疗机构导致死亡的主要原因。这些感染疾病通常源自于诊断过程共用用医疗设备，并可能导致人工呼吸器相关性肺炎、导管相关性尿道感染、中心静脉导管相关性血流感染疾病、手术部位感染疾病。

医院获得性感染 (HAI) 的发生受患者免疫系统状况、机构感染疾病控制措施以及医院环境中传染源的存在的影响。患者年龄和住院时间较长会显着增加感染风险，常见的与医院获得性感染相关的细菌包括大肠桿菌、耐甲氧西林金黄色葡萄球菌 (MRSA)、克雷伯氏菌、肠球菌和假单胞菌。

市场成长的关键驱动力

预防医院内感染

医院感染 (HAI) 发病率的上升是市场成长的根本驱动力，因为医疗机构优先考虑灭菌和消毒，以防止病毒在患者之间传播。最常见的感染疾病包括血流感染、肺炎、尿道感染和手术部位感染，其中手术部位感染是最大的成本驱动因素，因为它会增加住院时间和相关的诊断检查。

医疗机构使用先进的设备和程序实施全面的消毒通讯协定，以最大限度地降低感染风险、改善患者治疗效果并降低相关的医疗成本。

手术和人口趋势

由于老年人口不断增长以及慢性病的流行，外科手术数量不断增加，推动了市场需求的持续成长。老年人群更容易受到感染，因此需要加强感染疾病控制措施，并针对这群脆弱的患者群制定特殊通讯协定。

整合技术进步

灭菌设备的技术进步，包括电子束灭菌和环氧乙烷灭菌的重新引入，正透过提高灭菌效果和效率来支持市场扩张。这些进步使医疗机构能够实施更有效的感染疾病控制通讯协定，同时满足医疗设备和表面的多样化灭菌需求。

细分市场和应用领域

市场细分包括医疗机构、製药公司和医疗设备製造商的灭菌服务、设备製造和消耗品。食品灭菌和消毒应用将市场范围从医疗保健扩展到食品安全和加工行业。

製药公司、医院和医疗设备製造商之间的外包趋势为专业灭菌服务供应商创造了机会，同时透过服务多样化支持了整体市场的成长。

区域市场动态

在预测期内，北美将保持最大的市场份额，这得益于先进的医疗基础设施、监管要求以及整个医疗系统完善的感染疾病控制通讯协定。

市场限制与挑战

对化学消毒剂安全性的担忧

表面消毒剂、消毒液和灭菌剂的毒性以及接触化学消毒剂的副作用限制了市场的发展。次氯酸钠虽然能有效对抗血源性病原体，但其腐蚀性强，并具有呼吸道刺激性，对清洁人员和建筑物居住者构成风险。

对环境释放毒性的担忧限制了消毒剂的使用，尤其是在对环境永续解决方案的需求日益增长的情况下。消毒剂和杀菌剂缺乏绿色认证，限制了市场发展，製造商纷纷开发替代品，例如不含丁基、pH值中性的季铵盐和过氧化氢基配方。

竞争格局

市场领导者包括生产医疗设备、灭菌系统和消毒产品的老字型大小企业，例如 3M、Belimed、Cantel Medical、MMM Group、Sterigenics International LLC、STERIS plc、Matachana Group、Olympus Corporation 和 Medtronic。

战略意义

受医院感染预防需求、人口结构趋势和技术进步的推动，感染疾病控制市场正面临巨大的成长机会。成功的关键在于平衡感染疾病控制的有效性与环境永续性，同时透过创新产品开发和永续性替代解决方案来解决与化学消毒剂相关的安全问题。

本报告的主要优点

  • 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 分析范围
  • 细分市场

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球感染疾病控制市场（按产品）

  • 介绍
  • 消毒
  • 消毒
  • 巴氏杀菌
  • 热力灭菌
  • 绝育工作合约

第六章全球感染疾病控制市场（按最终用户产业）

  • 介绍
  • 医疗保健
  • 製药
  • 食品/饮料
  • 化学

第七章全球感染疾病控制市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪表板

第九章：公司简介

  • 3M
  • Belimed
  • Cantel Medical
  • MMM Group
  • Sterigenics International LLC
  • STERIS plc
  • HYH
  • Matachana Group
  • Olympus Corporation

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称

图表列表

表格列表

简介目录
Product Code: KSI061610975

Infection Control Market Size:

The global infection control market is expected to grow from USD 50.411 billion in 2025 to USD 62.063 billion in 2030, at a CAGR of 4.25%.

The infection control market encompasses practices and procedures designed to minimize infection and virus transmission risks, particularly in hospitals and healthcare facilities. This market addresses disease prevention from bacteria and viruses that spread through human-to-human contact, contaminated surfaces, and airborne transmission, representing critical healthcare infrastructure for patient safety and facility management.

Market Foundation and Clinical Significance

Infection control practices serve as essential safeguards against hospital-acquired infections (HAIs), which occur during patient facility stays and represent primary mortality causes in healthcare settings. These infections typically result from shared medical equipment usage during diagnostic procedures, leading to conditions including ventilator-associated pneumonia, catheter-associated urinary tract infections, central line-associated bloodstream infections, and surgical-site infections.

HAI development depends on patient immune system status, facility infection control practices, and infectious agent presence within hospital environments. Patient age and extended facility stays contribute significantly to infection risk, while common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species.

Primary Market Growth Drivers

Hospital-Acquired Infections Prevention

Growing HAI incidence represents the fundamental market driver, as healthcare facilities prioritize sterilization and disinfection practices to prevent patient-to-patient transmission. The most common infections include bloodstream infections, pneumonia, urinary tract infections, and surgical site infections, with surgical site infections representing the largest cost component due to prolonged hospitalization requirements and associated diagnostic testing.

Healthcare facilities implement comprehensive sterilization protocols using advanced equipment and procedures to minimize transmission risks and improve patient outcomes while reducing associated healthcare costs.

Surgical Procedures and Demographic Trends

Increasing surgical procedure volumes coupled with growing geriatric populations and chronic disease prevalence drive sustained market demand. Aging populations demonstrate higher infection susceptibility, requiring enhanced infection control measures and specialized protocols for vulnerable patient populations.

Technological Advancement Integration

Technological improvements in sterilization equipment, including E-beam sterilization and ethylene oxide sterilization reintroduction, support market expansion through enhanced efficacy and efficiency. These advances enable healthcare facilities to implement more effective infection control protocols while addressing diverse sterilization requirements across medical devices and facility surfaces.

Market Segmentation and Applications

The market segments include sterilization services, equipment manufacturing, and consumable products for healthcare facilities, pharmaceutical companies, and medical device manufacturers. Food sterilization and disinfection applications expand market scope beyond healthcare into food safety and processing industries.

Outsourcing trends among pharmaceutical companies, hospitals, and medical device manufacturers create opportunities for specialized sterilization service providers while supporting overall market growth through service diversification.

Geographic Market Dynamics

North America maintains the largest market share during the forecast period, supported by advanced healthcare infrastructure, regulatory requirements, and established infection control protocols across healthcare systems.

Market Constraints and Challenges

Chemical Disinfectant Safety Concerns

Adverse effects from chemical disinfectant exposure present ongoing market constraints due to toxic properties in surface disinfectants, sanitizers, and sterilizers. Sodium hypochlorite, while effective against blood-borne pathogens, demonstrates high corrosiveness and respiratory irritant properties, creating hazards for cleaning personnel and building occupants.

Environmental release toxicity concerns limit disinfectant usage, particularly given increasing demand for environmentally sustainable solutions. The absence of green certification for disinfectants and sterilizers restricts market expansion as manufacturers develop alternatives including butyl-free, pH-neutral quaternary, and hydrogen peroxide-based formulations.

Competitive Landscape

Market leadership includes established companies such as 3M, Belimed, Cantel Medical, MMM Group, Sterigenics International LLC, STERIS plc, Matachana Group, Olympus Corporation, and Medtronic, which manufacture healthcare equipment, sterilization systems, and disinfecting products.

Strategic Implications

The infection control market presents substantial growth opportunities driven by HAI prevention requirements, demographic trends, and technological advancement. Success requires balancing infection control efficacy with environmental sustainability while addressing safety concerns associated with chemical disinfectants through innovative product development and green alternative solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Infection Control Market Segments:

By Products

  • Disinfectants
  • Sterilization
  • Low-Temperature Sterilization
  • Heat Sterilization
  • Contract Sterilization

By End-User Industry

  • Healthcare
  • Pharmaceuticals
  • Food and Beverage
  • Chemical

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL INFECTION CONTROL MARKET BY PRODUCTS

  • 5.1. Introduction
  • 5.2. Disinfectants
  • 5.3. Sterilization
  • 5.4. Low-Temperature Sterilization
  • 5.5. Heat Sterilization
  • 5.6. Contract Sterilization

6. GLOBAL INFECTION CONTROL MARKET BY END-USER INDUSTRY

  • 6.1. Introduction
  • 6.2. Healthcare
  • 6.3. Pharmaceuticals
  • 6.4. Food and Beverage
  • 6.5. Chemical

7. GLOBAL INFECTION CONTROL MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. 3M
  • 9.2. Belimed
  • 9.3. Cantel Medical
  • 9.4. MMM Group
  • 9.5. Sterigenics International LLC
  • 9.6. STERIS plc
  • 9.7. HYH
  • 9.8. Matachana Group
  • 9.9. Olympus Corporation

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES